These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 6410534
1. The stability of factor VIII in heparinized plasma. Krachmalnicoff A, Thomas DP. Thromb Haemost; 1983 Jun 28; 49(3):224-7. PubMed ID: 6410534 [Abstract] [Full Text] [Related]
2. Dissociation of factor VIII procoagulant antigen VIII:CAg and factor VIII related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag. Tran TH, Duckert F. Thromb Haemost; 1983 Aug 30; 50(2):547-51. PubMed ID: 6415848 [Abstract] [Full Text] [Related]
3. The assay of factor VIII: C in heparinized plasma: a polybrene neutralization method. Cumming AM, Wensley RT, Delamore IW. Thromb Haemost; 1986 Feb 28; 55(1):58-60. PubMed ID: 3085265 [Abstract] [Full Text] [Related]
4. Disparity between one- and two-stage factor VIII assays in measuring VIIIC in heparinized plasma. Rock G, Palmer DS. Thromb Haemost; 1985 Dec 17; 54(4):780-3. PubMed ID: 3937275 [Abstract] [Full Text] [Related]
5. Use of plasma with high levels of ionised calcium in the production of model scale coagulation factor concentrates. Farrugia A, Douglas S, James J, Whyte G, Herrington R. Thromb Haemost; 1990 Nov 30; 64(3):374-8. PubMed ID: 2128967 [Abstract] [Full Text] [Related]
6. Stability of VIII:C in plasma: the dependence on protease activity and calcium. Rock GA, Cruickshank WH, Tackaberry ES, Ganz PR, Palmer DS. Thromb Res; 1983 Mar 01; 29(5):521-35. PubMed ID: 6407138 [Abstract] [Full Text] [Related]
7. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate. Prowse CV, Griffin B, Pepper DS, Dickson AJ, McQuillan TA, Dickson IH, Foster PR. Thromb Haemost; 1981 Oct 01; 46(3):597-601. PubMed ID: 6797090 [Abstract] [Full Text] [Related]
9. Standardization of Factor VIII-III. Establishment of a stable reference plasma for Factor VIII-related activities. Barrowcliffe TW, Tydeman MS, Kirkwood TB, Thomas DP. Thromb Haemost; 1983 Oct 31; 50(3):690-6. PubMed ID: 6417818 [Abstract] [Full Text] [Related]
10. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography. Orthner CL. J Lab Clin Med; 1984 Nov 31; 104(5):816-28. PubMed ID: 6436416 [Abstract] [Full Text] [Related]
15. [Factor VIII complex activities in acute leukemia]. Pniejnia-Olszyński W, Lopaciuk S. Acta Haematol Pol; 1980 Nov 31; 11(4):239-47. PubMed ID: 6794320 [Abstract] [Full Text] [Related]
16. Effect of plasma freezing temperature, anticoagulant and time of storage on factor VIII:C activity in cryoprecipitate. Piedras J, Sánchez-Montero PE, Herrera FM, Córdova MS, Sánchez-Medal L. Arch Med Res; 1993 Nov 31; 24(1):23-6. PubMed ID: 8292873 [Abstract] [Full Text] [Related]
18. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease. Chediak J, Peake I, Bloom A. Thromb Haemost; 1983 Aug 30; 50(2):509-12. PubMed ID: 6415844 [Abstract] [Full Text] [Related]
19. Rabbit antibodies against the procoagulant activity (VIII:C) of human factor VIII. Some theoretical and practical considerations on the human factor VIII molecule using heterologous antibodies. Tran TH, Marbet GA, Duckert F. Thromb Haemost; 1981 Dec 23; 46(4):699-705. PubMed ID: 6800051 [Abstract] [Full Text] [Related]
20. The APTT response of pregnant plasma to unfractionated heparin. Chunilal SD, Young E, Johnston MA, Robertson C, Naguit I, Stevens P, Galashan D, Oskamp ML, Brennan B, Ginsberg JS. Thromb Haemost; 2002 Jan 23; 87(1):92-7. PubMed ID: 11848463 [Abstract] [Full Text] [Related] Page: [Next] [New Search]